Friday, October 23, 2026

Government AI Contractors Report Revenue Surge as Federal Agencies Accelerate Spending

Palantir and Innodata posted strong Q3 2025 earnings driven by federal AI contracts, signaling accelerated government technology spending. Multiple contract awards spanning defense and civilian agencies suggest sustained revenue growth through 2026. The trend points to expanded government IT budget allocations in upcoming fiscal cycles.

Government AI Contractors Report Revenue Surge as Federal Agencies Accelerate Spending
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

Federal AI service providers reported accelerated revenue growth in Q3 2025, with government contracts driving earnings beats across multiple companies.

Palantir Technologies posted 35% year-over-year revenue growth in its government segment, reaching $726 million for the quarter. The company attributed gains to expanded Defense Department AI deployments and new Homeland Security analytics contracts. Government revenue now represents 56% of Palantir's total business, up from 51% in Q3 2024.

Innodata reported 89% government revenue growth, hitting $48 million in Q3. The data services firm secured five new federal AI training contracts during the quarter, including deals with the Department of Energy and NASA. Management raised full-year guidance by 12%, citing "unprecedented demand for AI data preparation services" from civilian agencies.

Contract awards accelerated through Q3 and into Q4. The General Services Administration issued $340 million in AI modernization task orders in September alone. Defense agencies awarded $892 million in machine learning infrastructure contracts between July and October, according to federal procurement data.

The earnings momentum reflects broader government AI spending trends. The White House AI budget request for fiscal 2026 seeks $3.2 billion, up 28% from 2025 levels. Congress allocated an additional $1.8 billion for agency AI implementation in the December 2025 appropriations bill.

Analysts project sustained growth for government-focused AI contractors. Goldman Sachs estimates the federal AI services market will reach $12 billion by end of 2026, up from $7.3 billion in 2024. Morgan Stanley forecasts 40-60% annual revenue growth for top contractors through 2027.

Stock performance tracked earnings strength. Palantir shares gained 47% in Q4 2025, while Innodata rose 183% over the same period. Both stocks trade at premium valuations: Palantir at 28x forward sales, Innodata at 4.2x.

Defense contractors with AI capabilities also benefited. Booz Allen Hamilton grew federal digital revenue 31% year-over-year, while SAIC reported 22% growth in its intelligence analytics business.

The trend suggests government AI procurement will remain a key earnings driver through 2026, particularly for companies with existing agency relationships and security clearances.

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Crunch: Late-Stage Readouts and Regulatory Milestones Converge on the Ivonescimab PDUFA Date
October 2026 is dense with clinical and regulatory news. Phase 3 trials hit primary endpoints (ALOFT-IPF, RESTORE-3), long-term data came out (MIUDELLA at 6 years, QUILT-3.032), and the FDA accepted Roche's vamikibart BLA. Scholar Rock resubmitted its apitegromab MAA to the EMA. The next catalysts are ESMO 2026 (Oct 23) and the Nov 14 FDA PDUFA date for ivonescimab, followed by Maritime-1 primary completion in January 2027. The speculative QAIAx items (QIII pilot, microcities patent) are a weak, tangential thread with little financial substance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,426 source documents archived
Query this data → isubstrate.com